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1. Characterisation Data 
1H NMR and 13C{1H}  NMR shown for each compound. High resolution mass spectrometry 
(HR-MS) using ESI is displayed for all compounds aside from the quinone species – which 
were characterised with APCI. 
2,5-dimethoxybenzoyl chloride 
 
This compound was synthesised following a literature procedure [1]. 2,5-dimethoxybenzoic 
acid (1.00 g, 5.49 mmol) was dissolved in dry toluene (10 mL) and drops of DMF were added. 
The solution was stirred under N2 atmosphere until all 2,5-dimethoxybenzoic acid had 
dissolved and was subsequently cooled to 0 °C in an ice bath. Following this, a portion on 
oxalyl chloride (0.732 g, 5.76 mmol) was added dropwise and the solution stirred at 0 °C for a 
further 30 minutes. The mixture was then stirred at room temperature for a further 2.5 hours 
before the solvent was removed on a rotary evaporator to leave a yellow oil (0.941 g, 4.69 
mmol, 85%). 1H NMR and mass spec were not obtained, as the product was used immediately 
for subsequent reactions.  
 
 
 2,5-dimethoxy-N-phenylbenzamide 
 
This compound was also synthesised following the same procedure [1]. 2,5-dimethoxybenzoyl 
chloride (1.00 g, 4.99 mmol) was dissolved in acetonitrile (18 mL) before a portion of K2CO3 
(0.800 g, 5.79 mmol) was added. Subsequently, aniline (0.464 g, 4.99 mmol) was added and 
the mixture left to stir at room temperature for 2 days. The solvent was removed on a rotary 
evaporator before the resultant solid was redissolved in EtOAc and washed with 1M NaOH 
solution. The solvent was again removed, and the solid recrystallised from diethyl ether to yield 
the product (0.634 g, 2.47 mmol, 50%). The NMR spectra were found to be consistent with 
literature spectra. 
2,5-dimethoxy-N-(p-tolyl)benzamide 
 
2,5-dimethoxybenzoyl chloride (0.941 g, 4.69 mmol) was dissolved in acetonitrile (20 mL) 
before a portion of K2CO3 (0.840 g, 6.08 mmol) was added. Subsequently, p-toluidine (0.502 
g, 4.69 mmol) was added and the mixture left to stir at room temperature for 2 days. The solvent 
was removed on a rotary evaporator before the resultant solid was redissolved in EtOAc and 
washed with 1M NaOH solution. The solvent was again removed to leave a brown oil, which 
recrystallised from ether to yield a yellowish-white product (0.488 g, 1.80 mmol, 38%).  
1H NMR (400 MHz, CDCl3-d) δ ppm 10.06 (1 H, s), 7.62 (2 H, d, J 8.4), 7.23 (1 H, d, J 3.0), 
7.14 (2H, d, J 8.5), 7.08 (2 H, d, J 3.0), 3.86 (3 H, s), 3.75 (3 H, s), 2.27 (3 H, s); 13C{1H} NMR 
(101 MHz, CDCl3-d) δ ppm 162.8, 154.1, 151.5, 135.9, 133.8, 129.5, 122.4, 120.4, 119.8, 
115.6, 113.3, 56.9, 55.8, 20.9. 
LR-MS (ESI+) m/z 294.16 [M + Na]+, 565.20 [2M + Na]
+; HR-MS (ESI+) calcd for C16H17NO3 
[M+Na]+: 294.11061, found m/z 294.11205  
 
 
Figure 1. 1H NMR (400 MHz) spectrum of 2,5-dimethoxy-N-(p-tolyl)benzamide in (CD3)2SO3 at 298 
K.  
 Figure 2. 13C{1H} NMR (101 MHz) spectrum of 2,5-dimethoxy-N-(p-tolyl)benzamide in (CD3)2SO3  at 
298 K.  
 
Figure 3. LR-MS (ESI+) of 2,5-dimethoxy-N-(p-tolyl)benzamide. 
 Figure 4. HR-MS of 2,5-dimethoxy-N-(p-tolyl)benzamide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 N-(4-fluorophenyl)-2,5-dimethoxybenzamide 
 
 
 
2,5-dimethoxybenzoyl chloride (0.690 g, 3.44 mmol) was dissolved in acetonitrile (20 mL) 
before a portion of K2CO3 (0.625 g, 4.52 mmol) was added. Subsequently, 4-fluoroanline 
(0.382 g, 3.44 mmol) was added and the mixture left to stir at room temperature for 2 days. 
The solvent was removed on a rotary evaporator before the resultant solid was redissolved in 
EtOAc and washed with 1M NaOH solution. The solvent was again removed, and the solid 
recrystallised from ether to yield a fine, white crystalline product (0.515 g, 1.87 mmol, 55%).  
1H NMR (500 MHz, DMSO-d6) 10.17 (1 H, s), 7.76 (2 H, dd, J 9.0, 5.1), 7.21 (1 H, d, J 3.0), 
7.18 (2 H, t, J 8.9), 7.12 (1 H, d, J 9.0), 7.07 (1 H, dd, J 9.0, 3.0), 3.85 (3 H, s), 3.75 (3 H, s); 
13C{1H} NMR (101 MHz, DMSO-d6) δ ppm 164.4 (s), 158.7 (d, J 240.1), 153.5 (s), 151.1 (s), 
135.8 (d, J 2.5), 125.7 (s), 122.0 (d, J 7.8), 117.8 (s), 115.7 (d, J 22.2), 115.0 (s), 114.0 (s), 56.9 
(s), 56.1 (s). 
LR-MS (ESI+) m/z 298.13 [M + Na]+, 573.16 [2M + Na]+; HR-MS (ESI+) calcd for 
C15H14FNO3 [M+Na]
+: 298.08554, found m/z 298.08499. 
 
 Figure 5. 1H NMR (500 MHz) spectrum of N-(4-fluorophenyl)-2,5-dimethoxybenzamide in (CD3)2SO3  
at 298 K. 
 
Figure 6. 13C{1H} NMR (101 MHz) spectrum of N-(4-fluorophenyl)-2,5-dimethoxybenzamide in 
(CD3)2SO at 298 K. 
  
Figure 7. LR-MS (ESI+) of N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
 
Figure 8. HR-MS (ESI+) of N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
 
N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide 
 
2,5-dimethoxybenzoyl chloride (1.00 g, 4.99 mmol) was dissolved in acetonitrile (20 mL) 
before a portion of K2CO3 (0.892 g, 6.45 mmol) was added. Subsequently, 3,5-
(trifluoromethoxy)aniline (1.1143 g, 4.99 mmol) was added and the mixture left to stir at room 
temperature for 2 days. The solvent was removed on a rotary evaporator before the resultant 
solid was redissolved in EtOAc and washed with 1M NaOH solution. The solvent was again 
removed, and the solid recrystallised from ether to yield a dark yellow product (1.357 g, 3.45 
mmol, 69%).  
1H NMR (500 MHz, DMSO-d6) δ ppm 10.72 (1 H, s), 8.46 (2 H, s), 7.79 (1 H, s), 7.24 (1 H, 
d, J 2.9), 7.15 (1 H, d, J 9.0), 7.12 (1 H, dd, J 9.0, 2.9), 3.86 (3 H, s), 3.76 (3 H, s); 13C{1H} 
NMR (101 MHz, CDCl3-d) δ ppm 165.6 (s), 153.5 (s), 151.2 (s), 141.3 (s), 131.2 (q, J 32.8), 
124.9 (s), 123.7 (q, J 272.8), 120.0 (d, J 3.0), 118.5 (s), 116.8 (dt, J 7.3, 3.7), 115.1 (s), 114.0 
(s), 56.9 (s), 56.1 (s). 
LR-MS (ESI+) m/z 416.12 [M + Na]+, 809.05 [2M + Na]+; HR-MS (ESI+) calcd for 
C17H13F6NO3 [M+Na]
+: 416.06973, found m/z 416.06918 
 
 Figure 9. 1H NMR (500 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide in (CD3)2SO at 298 K. 
 
Figure 10. 13C{1H} NMR (101 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide in (CD3)2SO at 298 K. 
 Figure 11. LR-MS (ESI+) of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
 
 
Figure 12. HR-MS (ESI+) of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
 
 
 
2,5-dihydroxy-N-phenylbenzamide 
 
 
This compound was synthesised following literature procedure [1]. 2,5-dimethoxy-N-
phenylbenzamide (0.418 g, 1.62 mmol) was dissolved as much as possible in dry DCM (5 mL), 
and the solution was cooled to 0 °C under a N2 atmosphere. Subsequently, BBr3 (1.947 g, 7.77 
mmol) in 1M DCM solution (7.7 mL) was added dropwise, and the mixture sustained at 0 °C 
for 1 hour. The solution was allowed to warm to room temperature and stirred for another 5 
hours. Following this, the solution was poured into a conical flask and deionised water (20 mL) 
was poured in to elicit the formation of a precipitate. This mixture was stirred for 15 minutes, 
and deionised water was also added to the original rbf to collect any residue. Next, the 
precipitate was filtered using a Büchner funnel and the solid washed with hexane (3 x 30 mL). 
The solid was collected from the filter paper and dried under vacuum to afford a brown solid 
(0.358 g, 1.56 mmol, 96%). The NMR spectra were consistent with those previously obtained 
in the literature. 
 
 
 
 
 
 
 
 
 
 
2,5-dihydroxy-N-(p-tolyl)benzamide 
 
 
2,5-dimethoxy-N-(p-tolyl)benzamide (0.198 g, 0.74 mmol) was dissolved as much as possible 
in dry DCM (7  mL), and the solution was cooled to 0 °C under a N2 atmosphere. Subsequently, 
BBr3 (1.052 g, 4.2 mmol) in 1M DCM solution (4.2 mL) was added dropwise. The clear 
solution immediately changed to milky white and the temperature was sustained at 0 °C for 1 
hour. The solution was allowed to warm to room temperature and stirred overnight. Following 
this, the solution had turned back to clear and was poured into a conical flask before deionised 
water (20 mL) was poured in to elicit the formation of a whitish-brown precipitate. This mixture 
was stirred for 15 minutes, and deionised water was also added to the original rbf to collect any 
residue. Next, the precipitate was filtered using a Büchner funnel and the solid washed with 
hexane (3 x 30 mL). The solid was collected from the filter paper and dried under vacuum to 
afford a whitish-brown solid (0.164 g, 0.67 mmol, 92%). 
1H NMR (400 MHz, DMSO-d6) δ ppm 10.32 (1 H, s), 7.57 (2 H, d, J 8.3), 7.36 (1 H, d, J 2.8), 
7.15 (2 H, d, J 8.3), 6.88 (1 H, dd, J 8.8, 2.9), 6.81 (1 H, d, J 8.8), 2.27 (3 H, s); 13C{1H} NMR 
(101 MHz, DMSO-d6) δ ppm 165.9 (s), 150.8 (s), 149.8 (s), 135.8 (s), 133.2 (s), 129.3 (s), 
120.9 (s), 120.7 (s), 117.9 (s), 114.7 (s), 114.5 (s), 20.5 (d, J 16.1). 
LR-MS (ESI+) 266.10 [M + Na]+; HR-MS (ESI+) calcd for C14H13NO3 [M+Na]
+: 266.07931, 
found m/z 266.07876 
 
 Figure 17. 1H NMR (400 MHz) spectrum of 2,5-dihydroxy-N-(p-tolyl)benzamide in (CD3)2SO at 298 
K. 
 
Figure 18. 13C{1H} NMR (101 MHz) spectrum of 2,5-dihydroxy-N-(p-tolyl)benzamide in (CD3)2SO at 
298 K. 
  
Figure 19. LR-MS (ESI+) of 2,5-dihydroxy-N-(p-tolyl)benzamide. 
 
Figure 20. HR-MS (ESI+) of 2,5-dihydroxy-N-(p-tolyl)benzamide. 
 
 
 
 
N-(4-fluorophenyl)-2,5-dihydroxybenzamide  
 
 
 
N-(4-fluorophenyl)-2,5-dimethoxybenzamide (0.045 g, 0.16 mmol) was dissolved in dry DCM 
(6 mL), and the solution was cooled to 0 °C under a N2 atmosphere. Subsequently, BBr3 (0.213 
g, 0.85 mmol) in 1M DCM solution (1 mL) was added dropwise. The purple solution 
immediately changed to dark brown and the temperature sustained at 0 °C for 1 hour. The 
solution was then allowed to warm to room temperature and stirred overnight. Following this, 
the solution was a lighter brown in colour and was poured into a conical flask before deionised 
water (20 mL) was poured in to elicit the formation of a precipitate. This mixture was stirred 
for 15 minutes, and deionised water was also added to the original rbf to collect any residue. 
Next, the precipitate was filtered using a Büchner funnel and the solid washed with hexane (3 
x 30 mL). The solid was collected from the filter paper and dried under vacuum to afford a 
whitish-brown solid (0.034 g, 0.14 mmol, 83%).  
1H NMR (500 MHz, DMSO-d6) δ ppm 11.00 (1 H, s), 10.39 (1 H, s), 9.09 (1 H, s), 7.71 (2 H, 
dd, J 9.0, 5.0), 7.34 (1 H, d, J 2.9), 7.19 (2 H, t, J 8.9), 6.88 (1 H, dd, J 8.8, 2.9), 6.82 (1 H, d, J 
8.8); 13C{1H} NMR (101 MHz, DMSO-d6) δ ppm 166.4 (s), 159.0 (d, J 240.7), 151.2 (s), 150.1 
(s), 135.1 (d, J 2.6), 123.1 (d, J 7.9), 121.6 (s), 118.3 (s), 118.2 (s), 115.8 (d, J 22.2), 114.9 (s). 
LR-MS (ESI-) m/z 246.07 [M - H]-, 493.18 [2M - H]-; HR-MS (ESI-) calcd for C13H10FNO3 
[M-H]-: 246.05653, found m/z 246.05719. 
 
 Figure 21. 1H NMR (500 MHz) spectrum of N-(4-fluorophenyl)-2,5-dihydroxybenzamide in (CD3)2SO 
at 298 K. 
 
Figure 22. 13C{1H} NMR (101 MHz) spectrum of N-(4-fluorophenyl)-2,5-dihydroxybenzamide in 
(CD3)2SO at 298 K. 
  
Figure 23. LR-MS (ESI+) of N-(4-fluorophenyl)-2,5-dihydroxybenzamide. 
 
Figure 24. HR-MS (ESI+) of N-(4-fluorophenyl)-2,5-dihydroxybenzamide. 
 
 
 
N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dihydroxybenzamide 
 
 
N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide (0.515 g, 1.31 mmol) was 
dissolved as much as possible in dry DCM (6 mL), and the solution was cooled to 0 °C under 
a N2 atmosphere. Subsequently, BBr3 (1.658 g, 6.62 mmol) in 1M DCM solution (6.6 mL) was 
added dropwise. The clear solution immediately changed to yellow in colour and the 
temperature sustained at 0 °C for 1 hour. The solution was then allowed to warm to room 
temperature and stirred for another 5 hours. Following this, the solution was poured into a 
conical flask and deionised water (20 mL) was poured in to elicit the formation of a green 
precipitate, which turned white after being in water for 15 minutes. In addition, deionised water 
was also added to the original rbf to collect any residue which was also stirred in deionised 
water for 15 minutes. Next, the precipitate was filtered using a Büchner funnel and the solid 
washed with hexane (3 x 30 mL). The solid was collected from the filter paper and dried under 
vacuum to afford a whitish-brown solid (0.395 g, 1.508 mmol, 83%).  
1H NMR (500 MHz, DMSO-d6) δ ppm 10.82 (1 H, s), 10.68 (1 H, s), 9.16 (1 H, s), 8.45 (2 H, 
s), 7.80 (1 H, s), 7.29 (1 H, d, J 2.5), 6.91 (1 H, dd, J 8.8, 2.8), 6.85 (1 H, d, J 8.8); 13C{1H} 
NMR (101 MHz, DMSO-d6) δ ppm 167.0 (s), 150.7 (s), 150.3 (s), 140.9 (s), 131.2 (q, J 32.8), 
123.7 (q, J 272.7), 122.0 (s), 120.7 (q[poorly defined], J 3.3), 118.6 (s), 118.4 (s), 117.0 (s), 
115.1 (s). 
LR-MS (ESI-) m/z 363.85 [M - H]-; HR-MS (ESI+) calcd for C15H9F6NO3 [M+Na]
+: 
388.03843, found m/z 388.03788 
 
 Figure 25. 1H NMR (500 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide in (CD3)2SO at 298 K. 
 
Figure 26. 13C{1H} NMR (101 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide in (CD3)2SO at 298 K. 
 Figure 27. LR-MS (ESI-) of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
 
Figure 28. HR-MS (ESI+) of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
 
 
 
 
 
3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide 
 
 
 
2,5-dimethoxy-N-phenylbenzamide (0.080 g, 0.35 mmol) and Mg2SO4 (0.235 g, 1.95 mmol) 
were suspended in DCM (16 ml). To this suspension was added Ag2O (0.145 g, 0.63 mmol) 
and the reaction was left to stir for 2 hours, which turned to orange in colour. The reaction was 
tracked via TLC using a 50% EtOAc/Hex solvent mixture. Having reached completion, the 
solution was filtered through celite and the solvent removed on a rotary evaporator to leave a 
bright orange solid (0.067 g, 0.3 mmol, 85%). 
1H NMR (400 MHz, CDCl3) δ ppm 10.29 (1 H, s), 7.78 (1 H, s), 7.69 (2 H, d, J 7.8), 7.38 (2 
H, t, J 7.9, 7.4), 7.18 (1 H, t, J 7.4), 6.89 (2 H, s); 13C{1H} NMR (101 MHz, CDCl3-d)) δ ppm 
188.7, 187.1, 158.5, 139.9, 137.2, 137.1, 134.8, 129.2, 125.4, 120.7. 
LR-MS (APCI) m/z 228.01 [M+H]+; HR-MS (APCI) calcd for C13H8NO3 [M+H]
+: 228.05824, 
found m/z 228.06552. 
 
 Figure 29. 1H NMR (400 MHz) spectrum of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide in 
CDCl3 at 298 K. 
 
Figure 30. 13C{1H} NMR (101 MHz) spectrum of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-
carboxamide in CDCl3 at 298 K. 
 Figure 31. LR-MS (APCI) of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide. 
 
Figure 32. HR-MS (APCI) of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide. 
 
 
 
 
 
 
3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide 
 
 
 
2,5-dihydroxy-N-(p-tolyl)benzamide (0.060 g, 0.25 mmol) and Mg2SO4 (0.400 g, 2.90  mmol) 
were suspended in DCM (16 ml). To this suspension was added Ag2O (0.340 g, 1.48 mmol) 
and the reaction was left to stir overnight. The day after, the reaction mixture had turned orange 
in colour and was filtered through celite. The solvent of the subsequent solution was removed 
on a rotary evaporator to leave a bright red solid (0.031 g, 0.13 mmol, 52%). 
1H NMR (400 MHz, CDCl3) δ ppm 10.23 (1 H, s), 7.76 (1 H, s), 7.57 (2 H, d, J 8.4), 7.17 (2 
H, d, J 8.2), 6.87 (2 H, s), 2.34 (3 H, s). 13C{1H} NMR (101 MHz, CDCl3) δ ppm 188.7, 187.1, 
158.4, 139.7, 137.2, 137.0, 135.2, 134.9, 134.8, 129.7, 120.6, 21.0. 
LR-MS (APCI) m/z 242.05 [M+H]+; HR-MS (APCI) calcd for C13H8NO3 [M]: 241.07389, 
found m/z 241.07433. 
  
 Figure 33. 1H NMR (400 MHz) spectrum of 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide 
in CDCl3 at 298 K. 
 
Figure 34. 13C{1H} NMR (101 MHz) spectrum of 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-
carboxamide in CDCl3 at 298 K. 
 Figure 35. LR-MS (APCI) of 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide. 
 
Figure 36. HR-MS (APCI) of 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide. 
N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-carboxamide 
 
 
N-(4-fluorophenyl)-2,5-dihydroxybenzamide (0.045 g, 0.18 mmol) and Mg2SO4 (0.176 g, 1.46 
mmol) were suspended in DCM (12 ml). To this suspension was added Ag2O (0.201 g, 0.86 
mmol) and the reaction was left to stir overnight. The day after, the reaction mixture had turned 
orange in colour and was filtered through celite. The solvent of the subsequent solution was 
removed on a rotary evaporator to leave a red solid (0.039 g, 0.15 mmol, 84%). 
1H NMR (400 MHz, DMSO-d6) δ ppm 10.29 (1 H, s), 7.78 (1 H, d, J 1.2), 7.67 (2 H, dd, J 9.0, 
4.8), 7.07 (2 H, t, J 8.6), 6.90 (2 H, s); 13C{1H} NMR (101 MHz, CDCL3) δ ppm 188.7 (s), 
187.0 (s), 158.5 (s), 138.5 (d, J 279.3), 137.2 (s), 134.7 (s), 133.4 (s), 122.4 (d, J 7.9), 120.0 
(s), 115.9 (d, J 22.5). 
LR-MS (APCI) m/z 245.09  [M]; HR-MS (ESI-) calcd for C13H8FNO [M]: 245.04882, found 
m/z 245.0930. 
 
 Figure 37. 1H NMR (400 MHz) spectrum of N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide in CDCl3 at 298 K.  
 
Figure 38. 13C{1H} NMR (101 MHz) spectrum of N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-
1-carboxamide in CDCl3 at 298 K. 
 Figure 39. LR-MS (APCI) of N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-carboxamide. 
 
Figure 40. HR-MS (APCI) of N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-carboxamide. 
N-(3,5-bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide 
 
 
N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dihydroxybenzamide (0.042 g, 0.12 mmol) and 
Mg2SO4 (0.200 g, 1.66 mmol) were suspended in DCM (12 ml). To this suspension was added 
Ag2O (0.200 g, 0.86 mmol) and the reaction was left to stir overnight. The day after, the 
reaction mixture had turned orange in colour and was filtered through celite. The solvent of the 
subsequent solution was removed on a rotary evaporator to leave a bright red solid (0.040 g, 
0.11 mmol, 96%). 
1H NMR (400 MHz, CDCl3) δ ppm 10.67 (1 H, s), 8.20 (2 H, s), 7.79 (1 H, m), 7.68 (1 H, s), 
6.95 (2 H, d, J 1.1); 13C{1H} NMR (101 MHz, CDCl3) δ ppm 188.7 (s), 186.7 (s), 159.4 (s), 
140.7 (s), 138.7 (s), 137.5 (s), 137.2 (s), 134.0 (s), 132.7 (q, J 33.8), 123.1 (q, J 272.8), 120.5 
(d, J 3.0), 118.7 (s). 
LR-MS (APCI) m/z 364.03 [M + H]+; HR-MS (APCI) calcd for C15H7F6NO3 [M]:363.21542, 
found m/z 363.03330. 
 
 Figure 41. 1H NMR (400 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-
1,4-diene-1-carboxamide in CDCl3 at 298 K. 
 
Figure 42. 13C{1H} NMR (101 MHz) spectrum of N-(3,5-bis(trifluoromethyl)phenyl)-3,6-
dioxocyclohexa-1,4-diene-1-carboxamide in CDCl3 at 298 K. 
 Figure 43. LR-MS (APCI) of N-(3,5-bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide. 
 
Figure 44. HR-MS (APCI) of N-(3,5-bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide. 
2. Crystal Structures 
Single crystals were obtained from slow evaporation from a saturated acetonitrile solution 
containing the respective free receptors only. A suitable crystal was selected and [in a film of 
paratone on a micromount] on a SuperNova, Dual, Cu at home/near, Atlas diffractometer. The 
crystal was kept at 100(2) K during data collection. Using Olex2 [1], the structure was solved 
with the olex2.solve [2] structure solution program using Charge Flipping and refined with the 
ShelXL [3] refinement package using Least Squares minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), 
J. Appl. Cryst. 42, 339-341. 
2. Bourhis, L.J., Dolomanov, O.V., Gildea, R.J., Howard, J.A.K., Puschmann, H. (2015). 
Acta Cryst. A71, 59-75. 
3. Sheldrick, G.M. (2015). Acta Cryst. C71, 3-8. 
 
2.1 Crystal Data for N-(4-fluorophenyl)-2,5-dimethoxybenzamide: 
 
 
 
 
 
 
Table 2.1.1 Crystal data and structure refinement for N-(4-fluorophenyl)-2,5-
dimethoxybenzamide.  
  
Identification code  pag19_s1731  
Empirical formula  C13H10FNO3  
Formula weight  247.22  
Temperature/K  100(2)  
Crystal system  tetragonal  
Space group  I41/a  
a/Å  13.4738(10)  
b/Å  13.4738(10)  
c/Å  23.638(2)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  4291.3(7)  
Z  16  
ρcalcg/cm3  1.531  
μ/mm-1  0.121  
F(000)  2048.0  
Crystal size/mm3  0.195 × 0.166 × 0.158  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  3.48 to 55.326  
Index ranges  -12 ≤ h ≤ 12, 0 ≤ k ≤ 17, -30 ≤ l ≤ 30  
Reflections collected  2498  
Independent reflections  2498 [Rint = ?, Rsigma = 0.0725]  
Data/restraints/parameters  2498/429/331  
Goodness-of-fit on F2  1.093  
Final R indexes [I>=2σ (I)]  R1 = 0.1039, wR2 = 0.2745  
Final R indexes [all data]  R1 = 0.1394, wR2 = 0.3040  
Largest diff. peak/hole / e Å-3  0.63/-0.35  
 
 
 
 
 
 
 
 
 
 
Table 2.1.2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. Ueq is defined as 1/3 
of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
F1 4412(3) 3767(3) 4679.7(15) 51.4(10) 
O10 9077(3) 3640(3) 4130.1(15) 42.3(11) 
O17 10875(3) 3800(3) 3892.8(14) 41.8(11) 
O18 11721(3) 3810(3) 6177.5(15) 41.4(10) 
N8 8487(4) 3699(4) 5024(2) 35.6(11) 
C2 5411(5) 3737(5) 4749(3) 39.3(13) 
C3 6019(5) 3707(5) 4291(2) 41.8(14) 
C4 7046(5) 3675(5) 4355(2) 40.4(13) 
C5 7449(5) 3697(6) 4907(3) 35.2(13) 
C6 6800(6) 3730(20) 5365(3) 41.2(16) 
C7 5775(6) 3745(9) 5294(3) 40.9(15) 
C9 9244(4) 3689(4) 4650(2) 34.2(11) 
C11 10282(4) 3737(4) 4863(2) 31.0(11) 
C12 11053(4) 3786(4) 4469(2) 31.9(12) 
C13 12038(5) 3820(4) 4641(2) 35.4(12) 
C14 12277(4) 3835(4) 5206(2) 32.1(11) 
C15 11523(5) 3792(4) 5604(2) 32.8(12) 
C16 10533(5) 3742(4) 5440(2) 31.6(12) 
F1A 18139(18) 3680(18) 4740(14) 58(6) 
O10A 13510(20) 3960(20) 4154(8) 52(6) 
O17A 11690(20) 3980(20) 3902(8) 43(6) 
O18A 10790(20) 3680(20) 6164(9) 55(7) 
N8A 14099(15) 3750(20) 5055(10) 40(5) 
C2A 17140(20) 3700(50) 4801(16) 51(6) 
C3A 16540(20) 3730(40) 4342(14) 52(6) 
C4A 15520(20) 3780(30) 4414(14) 50(6) 
C5A 15142(17) 3730(30) 4975(14) 48(5) 
C6A 15770(20) 3770(60) 5438(14) 49(6) 
C7A 16800(20) 3750(120) 5355(16) 50(7) 
C9A 13352(15) 3820(30) 4669(9) 40(5) 
C11A 12293(16) 3830(30) 4871(10) 38(5) 
C12A 11529(18) 3830(30) 4471(9) 37(5) 
C13A 10529(19) 3820(30) 4630(12) 36(5) 
C14A 10280(20) 3720(30) 5183(12) 37(5) 
C15A 11010(20) 3780(30) 5593(9) 39(5) 
C16A 12000(20) 3780(30) 5437(10) 37(5) 
  
Table 2.1.3 Anisotropic Displacement Parameters (Å2×103) for N-(4-fluorophenyl)-2,5-
dimethoxybenzamide. The Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
F1 46(2) 72(3) 36.6(19) -1.5(18) -3.3(15) -0.7(18) 
O10 49(2) 61(3) 17.4(16) 6.5(16) -4.0(15) -2(2) 
O17 54(3) 61(3) 10.6(15) 7.4(16) 2.0(15) 0(2) 
O18 47(2) 62(3) 15.1(16) 3.7(16) -3.1(15) 0(2) 
N8 43(3) 44(3) 20(2) 6.5(19) -0.4(18) -1(2) 
C2 45(3) 44(3) 28(3) 0(3) -2(2) 0(3) 
C3 52(4) 54(4) 20(2) -1(2) -1(2) 0(3) 
C4 45(3) 47(3) 29(3) 5(2) 4(2) -1(3) 
C5 39(3) 33(3) 33(3) 4(2) 2(2) -1(3) 
C6 48(3) 53(4) 22(3) 3(3) 0(2) -1(3) 
C7 48(3) 52(4) 23(3) 0(3) 7(2) 1(3) 
C9 46(3) 36(3) 20(2) 4.7(19) 0.6(19) 3(2) 
C11 40(3) 35(3) 18(2) 7(2) 5.0(19) 2(2) 
C12 42(3) 38(3) 15(2) 4.4(19) 3(2) 3(3) 
C13 44(3) 40(3) 22(2) 2(2) 2(2) 2(3) 
C14 37(3) 38(3) 21(2) 2(2) 0(2) 2(2) 
C15 44(3) 38(3) 17(2) 4.9(19) 1(2) 5(3) 
C16 42(3) 36(3) 16(2) 6(2) 2.8(19) 1(2) 
F1A 52(11) 38(12) 84(16) -7(12) 16(10) -6(9) 
O10A 78(15) 48(13) 30(8) 2(9) 14(8) -7(12) 
O17A 51(13) 60(14) 19(8) -1(8) 1(8) -4(12) 
O18A 76(16) 61(14) 27(9) 16(10) 10(9) 14(13) 
N8A 59(9) 34(9) 26(8) -3(7) 12(7) -19(8) 
C2A 54(11) 42(12) 57(12) -9(10) 16(9) -13(10) 
C3A 55(11) 48(12) 53(12) -5(10) 17(9) -17(11) 
C4A 56(11) 47(11) 48(11) -5(10) 18(9) -19(10) 
C5A 58(9) 40(10) 44(10) -4(9) 12(8) -21(8) 
C6A 55(10) 41(12) 51(11) -6(11) 11(8) -20(10) 
C7A 55(11) 40(13) 55(12) -8(11) 12(9) -17(11) 
C9A 59(9) 34(9) 27(7) -4(7) 9(6) -13(8) 
C11A 54(9) 37(9) 23(8) -2(8) 3(6) -10(8) 
C12A 50(10) 39(10) 21(8) -5(7) 5(7) -11(9) 
C13A 50(10) 36(10) 20(9) -9(9) 6(7) -10(9) 
C14A 46(10) 42(11) 23(9) -2(9) 5(7) -8(9) 
C15A 49(11) 43(10) 24(8) 2(8) 2(7) -6(9) 
C16A 50(10) 40(10) 22(8) 0(8) -1(7) -8(9) 
  
Table 2.1.4 Bond Lengths for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
Atom Atom Length/Å   Atom Atom Length/Å 
F1 C2 1.357(7)   F1A C2A 1.36(2) 
O10 C9 1.252(6)   O10A C9A 1.252(18) 
O17 C12 1.383(6)   O17A C12A 1.381(18) 
O18 C15 1.381(6)   O18A C15A 1.386(18) 
N8 C5 1.425(8)   N8A C5A 1.417(19) 
N8 C9 1.349(7)   N8A C9A 1.362(18) 
C2 C3 1.359(9)   C2A C3A 1.35(2) 
C2 C7 1.378(8)   C2A C7A 1.39(2) 
C3 C4 1.393(10)   C3A C4A 1.39(2) 
C4 C5 1.412(8)   C4A C5A 1.42(2) 
C5 C6 1.393(9)   C5A C6A 1.39(2) 
C6 C7 1.392(9)   C6A C7A 1.398(19) 
C9 C11 1.489(8)   C9A C11A 1.504(19) 
C11 C12 1.396(7)   C11A C12A 1.397(18) 
C11 C16 1.406(7)   C11A C16A 1.395(19) 
C12 C13 1.390(9)   C12A C13A 1.40(2) 
C13 C14 1.374(7)   C13A C14A 1.358(19) 
C14 C15 1.386(8)   C14A C15A 1.385(19) 
C15 C16 1.391(9)   C15A C16A 1.39(2) 
  
 
 
 
 
 
 
 
 
 
 
 
Table 2.1.5 Bond Angles for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C9 N8 C5 128.0(5)   C9A N8A C5A 130(2) 
F1 C2 C3 120.1(6)   F1A C2A C7A 115(2) 
F1 C2 C7 117.8(6)   C3A C2A F1A 120(2) 
C3 C2 C7 122.1(6)   C3A C2A C7A 124(2) 
C2 C3 C4 120.8(5)   C2A C3A C4A 120(2) 
C3 C4 C5 118.9(5)   C3A C4A C5A 118(2) 
C4 C5 N8 123.8(6)   N8A C5A C4A 118(2) 
C6 C5 N8 117.7(5)   C6A C5A N8A 120(2) 
C6 C5 C4 118.5(6)   C6A C5A C4A 121(2) 
C7 C6 C5 122.0(7)   C5A C6A C7A 120(3) 
C2 C7 C6 117.7(6)   C2A C7A C6A 117(3) 
O10 C9 N8 120.5(5)   O10A C9A N8A 122(2) 
O10 C9 C11 120.2(5)   O10A C9A C11A 118(2) 
N8 C9 C11 119.3(5)   N8A C9A C11A 119.3(17) 
C12 C11 C9 118.4(5)   C12A C11A C9A 119.0(18) 
C12 C11 C16 118.0(5)   C16A C11A C9A 124.8(19) 
C16 C11 C9 123.6(5)   C16A C11A C12A 116.1(17) 
O17 C12 C11 121.9(5)   O17A C12A C11A 123(2) 
O17 C12 C13 116.9(5)   O17A C12A C13A 115(2) 
C13 C12 C11 121.1(5)   C11A C12A C13A 121.9(18) 
C14 C13 C12 120.6(5)   C14A C13A C12A 120(2) 
C13 C14 C15 119.2(5)   C13A C14A C15A 119(2) 
O18 C15 C14 121.7(5)   O18A C15A C16A 117(2) 
O18 C15 C16 117.3(5)   C14A C15A O18A 122(2) 
C14 C15 C16 121.0(5)   C14A C15A C16A 120.1(19) 
C15 C16 C11 120.0(5)   C15A C16A C11A 122(2) 
  
Table 2.1.6 Hydrogen Bonds for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
O17 H17 O10 0.84 1.81 2.496(6) 137.4 
O18 H18 O171 0.84 1.97 2.778(6) 160.8 
N8 H8 O182 0.88 2.33 3.162(6) 158.8 
O17A H17A O10A 0.84 1.79 2.52(4) 144.5 
O18A H18A O18A2 0.84 1.92 2.75(5) 166.4 
N8A H8A O17A1 0.88 2.48 3.33(3) 161.9 
17/4-Y,-3/4+X,1/4+Z; 25/4-Y,-3/4+X,5/4-Z 
Table 2.1.7 Torsion Angles for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
A B C D Angle/˚   A B C D Angle/˚ 
F1 C2 C3 C4 -180.0(6)   F1A C2A C3A C4A -178(5) 
F1 C2 C7 C6 -179.1(14)   F1A C2A C7A C6A 180(9) 
O10 C9 C11 C12 3.7(8)   O10A C9A C11A C12A 11(6) 
O10 C9 C11 C16 -176.7(5)   O10A C9A C11A C16A -173(4) 
O17 C12 C13 C14 178.3(5)   O17A C12A C13A C14A -177(4) 
O18 C15 C16 C11 179.0(5)   O18A C15A C16A C11A 177(4) 
N8 C5 C6 C7 179.0(16)   N8A C5A C6A C7A -180(9) 
N8 C9 C11 C12 -176.2(5)   N8A C9A C11A C12A -176(4) 
N8 C9 C11 C16 3.4(8)   N8A C9A C11A C16A 0(6) 
C2 C3 C4 C5 -1.4(10)   C2A C3A C4A C5A -4(8) 
C3 C2 C7 C6 0.4(18)   C3A C2A C7A C6A 5(18) 
C3 C4 C5 N8 -178.0(6)   C3A C4A C5A N8A -179(4) 
C3 C4 C5 C6 1.3(16)   C3A C4A C5A C6A 9(8) 
C4 C5 C6 C7 0(3)   C4A C5A C6A C7A -8(12) 
C5 N8 C9 O10 -2.5(9)   C5A N8A C9A O10A -7(6) 
C5 N8 C9 C11 177.4(6)   C5A N8A C9A C11A 180(4) 
C5 C6 C7 C2 -1(3)   C5A C6A C7A C2A 1(17) 
C7 C2 C3 C4 0.6(11)   C7A C2A C3A C4A -3(12) 
C9 N8 C5 C4 0.5(11)   C9A N8A C5A C4A 1(6) 
C9 N8 C5 C6 -178.8(14)   C9A N8A C5A C6A 173(5) 
C9 C11 C12 O17 0.7(8)   C9A C11A C12A O17A -11(6) 
C9 C11 C12 C13 -179.2(5)   C9A C11A C12A C13A 179(4) 
C9 C11 C16 C15 -179.8(5)   C9A C11A C16A C15A -179(4) 
C11 C12 C13 C14 -1.8(9)   C11A C12A C13A C14A -6(7) 
C12 C11 C16 C15 -0.2(8)   C12A C11A C16A C15A -3(7) 
C12 C13 C14 C15 1.5(9)   C12A C13A C14A C15A 10(6) 
C13 C14 C15 O18 -179.6(5)   C13A C14A C15A O18A -180(4) 
C13 C14 C15 C16 -0.6(9)   C13A C14A C15A C16A -10(7) 
C14 C15 C16 C11 -0.1(9)   C14A C15A C16A C11A 7(7) 
C16 C11 C12 O17 -179.0(5)   C16A C11A C12A O17A 173(4) 
C16 C11 C12 C13 1.1(9)   C16A C11A C12A C13A 3(7) 
  
 
 
 
Table 2.1.8 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
Atom x y z U(eq) 
H17 10310.35 3562.51 3827.15 63 
H18 12337.32 3822.12 6229.22 62 
H8 8653.77 3708.39 5383.4 43 
H3 5739.44 3708.22 3921.56 50 
H4 7467.85 3639.39 4033.93 48 
H6 7065.42 3740.09 5737.12 49 
H7 5340.57 3761.85 5610.6 49 
H13 12551.45 3833.32 4365.41 42 
H14 12951.04 3874.82 5322.12 39 
H16 10025.28 3711.92 5718.88 38 
H17A 12302.21 4059.81 3844.03 65 
H18A 10176.28 3665.68 6209.27 82 
H8A 13904.6 3722.37 5409.51 47 
H3A 16818.99 3726.82 3972.89 62 
H4A 15085.06 3851.05 4099.54 60 
H6A 15509.61 3816.72 5809.47 59 
H7A 17249.05 3765.74 5664.54 60 
H13A 10027.03 3883.34 4350.66 43 
H14A 9603.78 3609.75 5288.16 45 
H16A 12496.33 3751.06 5722.66 45 
  
 
 
 
 
 
 
 
 
 
 
Table 2.1.9 Atomic Occupancy for N-(4-fluorophenyl)-2,5-dimethoxybenzamide. 
Atom Occupancy   Atom Occupancy   Atom Occupancy 
F1 0.861(6)   O10 0.861(6)   O17 0.861(6) 
H17 0.861(6)   O18 0.861(6)   H18 0.861(6) 
N8 0.861(6)   H8 0.861(6)   C2 0.861(6) 
C3 0.861(6)   H3 0.861(6)   C4 0.861(6) 
H4 0.861(6)   C5 0.861(6)   C6 0.861(6) 
H6 0.861(6)   C7 0.861(6)   H7 0.861(6) 
C9 0.861(6)   C11 0.861(6)   C12 0.861(6) 
C13 0.861(6)   H13 0.861(6)   C14 0.861(6) 
H14 0.861(6)   C15 0.861(6)   C16 0.861(6) 
H16 0.861(6)   F1A 0.139(6)   O10A 0.139(6) 
O17A 0.139(6)   H17A 0.139(6)   O18A 0.139(6) 
H18A 0.139(6)   N8A 0.139(6)   H8A 0.139(6) 
C2A 0.139(6)   C3A 0.139(6)   H3A 0.139(6) 
C4A 0.139(6)   H4A 0.139(6)   C5A 0.139(6) 
C6A 0.139(6)   H6A 0.139(6)   C7A 0.139(6) 
H7A 0.139(6)   C9A 0.139(6)   C11A 0.139(6) 
C12A 0.139(6)   C13A 0.139(6)   H13A 0.139(6) 
C14A 0.139(6)   H14A 0.139(6)   C15A 0.139(6) 
C16A 0.139(6)   H16A 0.139(6)       
Crystal structure determination of N-(4-fluorophenyl)-2,5-dimethoxybenzamide 
Crystal Data for C13H10FNO3 (M =247.22 g/mol): tetragonal, space group I41/a (no. 88), a = 
13.4738(10) Å, c = 23.638(2) Å, V = 4291.3(7) Å3, Z = 16, T = 100(2) K, μ(MoKα) = 0.121 
mm-1, Dcalc = 1.531 g/cm3, 2498 reflections measured (3.48° ≤ 2Θ ≤ 55.326°), 2498 unique 
(Rint = ?, Rsigma = 0.0725) which were used in all calculations. The final R1 was 0.1039 (I > 
2σ(I)) and wR2 was 0.3040 (all data).  
Refinement model description  
Number of restraints - 429, number of constraints - unknown.  
 
 
 
 
 
 
Details: 
1. Twinned data refinement 
 Scales: 0.943(3) 
 0.057(3) 
2. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All N(H) groups 
 At 1.5 times of: 
  All O(H) groups 
3. Uiso/Uaniso restraints and constraints 
F1A ≈ O10A ≈ O17A ≈ O18A ≈ N8A ≈ C2A ≈ C3A ≈ C4A 
≈ C5A ≈ C6A ≈ C7A ≈ C9A ≈ C11A ≈ C12A ≈ C13A ≈ 
C14A ≈ C15A ≈ C16A: within 2A with sigma of 0.01 and sigma for terminal 
atoms of 0.02 
4. Rigid body (RIGU) restrains 
 All non-hydrogen atoms 
 with sigma for 1-2 distances of 0.004 and sigma for 1-3 distances of 0.004 
5. Same fragment restrains 
{F1, O10, O17, O18, N8, C2, C3, C4, C5, C6, C7, C9, C11, C12, C13, C14, 
C15, 
C16} sigma for 1-2: 0.02, 1-3: 0.04 
as 
{F1A, O10A, O17A, O18A, N8A, C2A, C3A, C4A, C5A, C6A, C7A, C9A, C11A, C12A, 
C13A, C14A, C15A, C16A} 
6. Others 
 
Sof(F1A)=Sof(O10A)=Sof(O17A)=Sof(H17A)=Sof(O18A)=Sof(H18A)=Sof(N8A)=Sof(H8A
)= 
 Sof(C2A)=Sof(C3A)=Sof(H3A)=Sof(C4A)=Sof(H4A)=Sof(C5A)=Sof(C6A)=Sof(H6A)= 
 
Sof(C7A)=Sof(H7A)=Sof(C9A)=Sof(C11A)=Sof(C12A)=Sof(C13A)=Sof(H13A)=Sof(C14A
)= 
 Sof(H14A)=Sof(C15A)=Sof(C16A)=Sof(H16A)=1-FVAR(1) 
 
Sof(F1)=Sof(O10)=Sof(O17)=Sof(H17)=Sof(O18)=Sof(H18)=Sof(N8)=Sof(H8)=Sof(C2
)= 
 Sof(C3)=Sof(H3)=Sof(C4)=Sof(H4)=Sof(C5)=Sof(C6)=Sof(H6)=Sof(C7)=Sof(H7)= 
 Sof(C9)=Sof(C11)=Sof(C12)=Sof(C13)=Sof(H13)=Sof(C14)=Sof(H14)=Sof(C15)= 
 Sof(C16)=Sof(H16)=FVAR(1) 
7.a Aromatic/amide H refined with riding coordinates: 
 N8(H8), C3(H3), C4(H4), C6(H6), C7(H7), C13(H13), C14(H14), C16(H16), 
 N8A(H8A), C3A(H3A), C4A(H4A), C6A(H6A), C7A(H7A), C13A(H13A), C14A(H14A), 
 C16A(H16A) 
7.b Idealised tetrahedral OH refined as rotating group: 
 O17(H17), O18(H18), O17A(H17A), O18A(H18A) 
 
 
 
 
 
2.2 Crystal data for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.2.1 Crystal data and structure refinement for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide.  
  
Identification code  pag19_s1730  
Empirical formula  C17H12F6N2O3  
Formula weight  406.29  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  11.9740(16)  
b/Å  4.8398(5)  
c/Å  29.092(3)  
α/°  90  
β/°  91.105(11)  
γ/°  90  
Volume/Å3  1685.6(3)  
Z  4  
ρcalcg/cm3  1.601  
μ/mm-1  1.372  
F(000)  824.0  
Crystal size/mm3  0.147 × 0.031 × 0.01  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.384 to 145.802  
Index ranges  -14 ≤ h ≤ 14, -5 ≤ k ≤ 5, 0 ≤ l ≤ 35  
Reflections collected  3231  
Independent reflections  3231 [Rint = ?, Rsigma = 0.0938]  
Data/restraints/parameters  3231/3/264  
Goodness-of-fit on F2  1.173  
Final R indexes [I>=2σ (I)]  R1 = 0.1123, wR2 = 0.3501  
Final R indexes [all data]  R1 = 0.1432, wR2 = 0.3707  
Largest diff. peak/hole / e Å-3  0.55/-0.52  
 
 
 
 
 
 
 
 
 
 
Table 2.2.2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. Ueq is 
defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
F1 11285(4) 11755(12) 4013.4(16) 43.9(13) 
F2 10927(4) 11406(11) 4729.3(15) 41.0(12) 
F3 10704(4) 15294(10) 4388.3(18) 43.2(12) 
F4 6841(4) 15505(12) 4934.8(17) 46.9(13) 
F5 5736(5) 14674(14) 4370.6(18) 54.9(15) 
F6 5967(6) 11613(12) 4904(2) 66.3(19) 
O1 9375(4) 6004(11) 3154.6(17) 30.0(12) 
O2 5954(4) 4105(12) 3220.6(18) 30.3(12) 
O3 8592(5) -1319(13) 1965.5(19) 37.1(13) 
N1 7715(5) 7071(13) 3474(2) 25.1(13) 
C1 8352(6) 5623(14) 3178(2) 23.6(14) 
C2 7767(6) 3529(15) 2885(2) 24.9(14) 
C3 6642(6) 2751(15) 2918(2) 24.0(14) 
C4 6201(6) 691(15) 2640(2) 26.0(15) 
C5 6864(6) -677(17) 2326(2) 29.3(16) 
C6 7990(6) 75(16) 2288(2) 25.5(15) 
C7 8426(6) 2143(16) 2563(2) 27.5(15) 
C8 8049(6) 9076(15) 3797(2) 24.5(14) 
C9 9154(6) 9880(16) 3881(2) 26.5(15) 
C10 9380(6) 11823(16) 4219(2) 27.1(15) 
C11 8537(6) 13026(16) 4473(2) 27.7(15) 
C12 7444(6) 12251(15) 4383(2) 27.1(15) 
C13 7195(6) 10275(16) 4051(2) 28.3(15) 
C14 10568(6) 12580(17) 4332(2) 28.3(15) 
C15 6504(7) 13484(18) 4647(3) 34.7(17) 
N2 4428(5) 251(15) 3574(2) 35.5(15) 
C16 3845(7) -1375(18) 3713(3) 33.8(17) 
C17 3105(8) -3454(19) 3892(3) 42(2) 
  
 
 
 
 
Table 2.2.3 Anisotropic Displacement Parameters (Å2×103) for N-(3,5-
bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
F1 26(2) 58(3) 47(3) -14(2) 7.2(19) -8(2) 
F2 41(3) 44(3) 37(2) 9(2) -7.2(19) -15(2) 
F3 34(3) 30(3) 66(3) 2(2) -4(2) -9(2) 
F4 43(3) 47(3) 51(3) -19(2) 7(2) 1(2) 
F5 38(3) 69(4) 57(3) -19(3) -2(2) 20(3) 
F6 71(4) 37(3) 93(4) -3(3) 52(3) -2(3) 
O1 18(2) 31(3) 40(3) -4(2) 3.1(19) -6(2) 
O2 23(3) 30(3) 38(3) -3(2) 10(2) 0(2) 
O3 29(3) 45(4) 38(3) -12(3) 8(2) -2(3) 
N1 18(3) 27(3) 30(3) -3(2) 5(2) 1(2) 
C1 23(3) 18(3) 30(3) 2(3) 0(3) 0(3) 
C2 21(3) 22(3) 32(3) 0(3) 2(3) -4(3) 
C3 20(3) 22(3) 30(3) 3(3) 4(2) 4(3) 
C4 16(3) 25(4) 37(4) 1(3) 1(3) 1(3) 
C5 29(4) 27(4) 31(3) 0(3) 0(3) 1(3) 
C6 19(3) 29(4) 29(3) -2(3) 2(2) 3(3) 
C7 21(3) 30(4) 32(3) 2(3) 5(3) 1(3) 
C8 19(3) 22(4) 32(3) 5(3) -1(3) -3(3) 
C9 22(3) 30(4) 28(3) 3(3) 2(3) -4(3) 
C10 31(4) 26(4) 24(3) 2(3) 1(3) 0(3) 
C11 24(4) 26(4) 32(3) 1(3) 2(3) -2(3) 
C12 27(4) 23(4) 31(3) 4(3) 5(3) -1(3) 
C13 24(3) 29(4) 32(3) 2(3) 1(3) -3(3) 
C14 21(3) 31(4) 33(4) -2(3) 4(3) -6(3) 
C15 29(4) 34(4) 41(4) -4(3) 6(3) -5(3) 
N2 24(3) 37(4) 46(4) 4(3) 4(3) -1(3) 
C16 27(4) 38(5) 37(4) 3(3) 5(3) 3(3) 
C17 37(4) 34(5) 56(5) 1(4) 7(4) -10(4) 
  
 
 
 
 
Table 2.2.4 Bond Lengths for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
Atom Atom Length/Å   Atom Atom Length/Å 
F1 C14 1.337(9)   C3 C4 1.383(11) 
F2 C14 1.350(9)   C4 C5 1.388(10) 
F3 C14 1.333(10)   C5 C6 1.403(10) 
F4 C15 1.344(10)   C6 C7 1.379(11) 
F5 C15 1.341(10)   C8 C9 1.397(10) 
F6 C15 1.346(10)   C8 C13 1.400(10) 
O1 C1 1.243(9)   C9 C10 1.385(11) 
O2 C3 1.382(8)   C10 C11 1.389(10) 
O3 C6 1.371(9)   C10 C14 1.500(10) 
N1 C1 1.356(9)   C11 C12 1.382(10) 
N1 C8 1.403(9)   C12 C13 1.387(11) 
C1 C2 1.491(10)   C12 C15 1.499(10) 
C2 C3 1.403(10)   N2 C16 1.132(11) 
C2 C7 1.407(10)   C16 C17 1.444(12) 
 
  
Table 2.2.5 Bond Angles for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C1 N1 C8 128.8(6)   C9 C10 C14 119.6(7) 
O1 C1 N1 121.7(6)   C11 C10 C14 118.5(7) 
O1 C1 C2 121.5(6)   C12 C11 C10 118.8(7) 
N1 C1 C2 116.8(6)   C11 C12 C13 120.6(7) 
C3 C2 C1 125.7(6)   C11 C12 C15 120.9(7) 
C3 C2 C7 118.0(7)   C13 C12 C15 118.6(7) 
C7 C2 C1 116.2(6)   C12 C13 C8 120.3(7) 
O2 C3 C2 120.1(7)   F1 C14 F2 105.7(6) 
O2 C3 C4 119.3(6)   F1 C14 C10 113.2(6) 
C4 C3 C2 120.6(6)   F2 C14 C10 111.7(6) 
C3 C4 C5 120.8(7)   F3 C14 F1 107.5(6) 
C4 C5 C6 119.4(7)   F3 C14 F2 105.9(6) 
O3 C6 C5 116.5(7)   F3 C14 C10 112.4(7) 
O3 C6 C7 123.8(6)   F4 C15 F6 106.5(6) 
C7 C6 C5 119.7(7)   F4 C15 C12 113.0(7) 
C6 C7 C2 121.4(7)   F5 C15 F4 104.8(7) 
C9 C8 N1 124.5(6)   F5 C15 F6 107.0(7) 
C9 C8 C13 119.5(7)   F5 C15 C12 112.1(6) 
C13 C8 N1 116.1(6)   F6 C15 C12 112.9(7) 
C10 C9 C8 119.0(7)   N2 C16 C17 179.7(10) 
C9 C10 C11 121.9(7)           
Table 2.2.6 Hydrogen Bonds for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
O2 H2 N2 0.84(2) 1.99(3) 2.818(9) 168(11) 
O3 H3 O11 0.84(2) 1.91(4) 2.711(8) 161(11) 
N1 H1 O2 0.88(2) 1.89(6) 2.645(8) 143(8) 
12-X,-1/2+Y,1/2-Z 
  
Table 2.2.7 Torsion Angles for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
A B C D Angle/˚   A B C D Angle/˚ 
O1 C1 C2 C3 173.2(7)   C8 C9 C10 C11 -1.0(11) 
O1 C1 C2 C7 -3.8(10)   C8 C9 C10 C14 176.4(7) 
O2 C3 C4 C5 178.8(6)   C9 C8 C13 C12 0.3(11) 
O3 C6 C7 C2 179.3(7)   C9 C10 C11 C12 0.0(11) 
N1 C1 C2 C3 -6.2(10)   C9 C10 C14 F1 15.2(10) 
N1 C1 C2 C7 176.8(6)   C9 C10 C14 F2 -103.9(8) 
N1 C8 C9 C10 -177.9(7)   C9 C10 C14 F3 137.2(7) 
N1 C8 C13 C12 179.1(7)   C10 C11 C12 C13 1.1(11) 
C1 N1 C8 C9 -2.5(11)   C10 C11 C12 C15 179.9(7) 
C1 N1 C8 C13 178.7(7)   C11 C10 C14 F1 -167.4(7) 
C1 C2 C3 O2 4.9(11)   C11 C10 C14 F2 73.5(9) 
C1 C2 C3 C4 -177.2(7)   C11 C10 C14 F3 -45.4(9) 
C1 C2 C7 C6 177.0(7)   C11 C12 C13 C8 -1.2(11) 
C2 C3 C4 C5 0.9(11)   C11 C12 C15 F4 5.5(11) 
C3 C2 C7 C6 -0.2(11)   C11 C12 C15 F5 123.6(8) 
C3 C4 C5 C6 -1.0(11)   C11 C12 C15 F6 -115.5(8) 
C4 C5 C6 O3 -178.8(7)   C13 C8 C9 C10 0.8(10) 
C4 C5 C6 C7 0.5(11)   C13 C12 C15 F4 -175.6(7) 
C5 C6 C7 C2 0.1(11)   C13 C12 C15 F5 -57.5(10) 
C7 C2 C3 O2 -178.2(6)   C13 C12 C15 F6 63.4(10) 
C7 C2 C3 C4 -0.3(10)   C14 C10 C11 C12 -177.3(7) 
C8 N1 C1 O1 -1.7(11)   C15 C12 C13 C8 179.9(7) 
C8 N1 C1 C2 177.7(6)             
  
 
 
Table 2.2.8 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide. 
Atom x y z U(eq) 
H2 5450(60) 3160(190) 3340(30) 46 
H3 9200(50) -500(200) 1990(40) 56 
H1 7000(20) 6680(190) 3460(30) 30 
H4 5435.86 206.99 2663.17 31 
H5 6557.61 -2109.56 2139.48 35 
H7 9189.04 2643.5 2534.57 33 
H9 9742.43 9103.88 3708.21 32 
H11 8709.57 14357.5 4703.2 33 
H13 6441.48 9731.76 3996.84 34 
H17A 2527.28 -3895.54 3660.36 63 
H17B 2752.91 -2753.75 4169.98 63 
H17C 3533.8 -5124.83 3967.04 63 
Crystal structure determination of [pag19_s1730]  
Crystal Data for C17H12F6N2O3 (M =406.29 g/mol): monoclinic, space group P21/c (no. 14), 
a = 11.9740(16) Å, b = 4.8398(5) Å, c = 29.092(3) Å, β = 91.105(11)°, V = 1685.6(3) Å3, Z = 
4, T = 100(2) K, μ(CuKα) = 1.372 mm-1, Dcalc = 1.601 g/cm3, 3231 reflections measured 
(7.384° ≤ 2Θ ≤ 145.802°), 3231 unique (Rint = ?, Rsigma = 0.0938) which were used in all 
calculations. The final R1 was 0.1123 (I > 2σ(I)) and wR2 was 0.3707 (all data).  
Refinement model description  
Number of restraints - 3, number of constraints - unknown.  
Details: 
1. Twinned data refinement 
 Scales: 0.694 
 0.306 
2. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All N(H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups, All O(H) groups 
3. Restrained distances 
 N1-H1 
 0.88 with sigma of 0.02 
 O2-H2 = O3-H3 
 0.84 with sigma of 0.02 
4.a Aromatic/amide H refined with riding coordinates: 
 C4(H4), C5(H5), C7(H7), C9(H9), C11(H11), C13(H13) 
4.b Idealised Me refined as rotating group: 
 C17(H17A,H17B,H17C) 
 
 
3.  1H NMR Titration Anion Binding Studies 
Equipment and Sample Preparation  
1H NMR titrations were performed on a Bruker Avance DPX 400 spectrometer. For NMR 
titrations with chloride, a constant host concentration was maintained (~ 5.0 mM) by using the 
host solution to dissolve the guest to make the guest stock solution. Over the course of the 
titration Hamiltonian Microlitre syringes were used to add aliquots of the guest stock solution 
to the NMR sample of the host solution.  
The anions were added as the tetrabutylammonium (TBA) salts after being dried under high 
vacuum (< 1.0 mmHg) for 24 h. Stock solutions of the host were prepared in a CD3CN / 1% 
DMSO-d6 solution, or a pure CD3CN solution. The solvent used is noted in the information for 
each titration. The host stock solutions (500 μL) were transferred to an air-tight screw-cap 
NMR sample tube (5 mm ID) and the same host stock solution was used to prepare the standard 
guest titrant solution containing 20-100 mM of the TBA-anion salts. This ensured a constant 
concentration of the host for the duration of the titration experiment.  
Titration Procedure  
Over the course of the titration small aliquots (2-100 μL) of the standard guest solution were 
added to the host solution (~ 500 μL) in the NMR tube. For each titration 15-20 data points 
were collected and at the end of the titration approximately 50 equivalents of the guest anion 
salt were present. Upon each addition of the standard guest solution the samples were 
thoroughly shaken in the NMR tube and then allowed to equilibrate for up to 2 minutes inside 
the NMR probe before the spectra were taken. Throughout each titration experiment all 
parameters of the NMR spectrometer remained constant.  
Titration Data Fitting  
In all cases the proton resonances were monitored for changes in chemical shift. Where possible 
two or more resonances were followed, allowing several data sets to use in determination of 
the association constant (Ka). Global fitting takes into account all data sets at the same time and 
improves the quality of the nonlinear curve fitting. The supramolecular.org web applet was 
used to fit the titration data to either a 1:1 binding model or 2:1 binding model. A 2:1 model 
was preferred when the covariance of fit (covfit) was greater than 5 times better than for the 1:1 
model. 
 Figure 45. 1H NMR titration spectra as a stack plot for 2,5-dimethoxy-N-phenylbenzamide (5 mM) + 
TBACl in CD3CN-d3 / 1% DMSO-d6 at 298 K.  
 
Figure 46. Fitted binding isotherm of 2,5-dimethoxy-N-phenylbenzamide + TBACl showing the change 
in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka = 2.18 M-1 Residual plot 
showing the random error obtained from the binding isotherm fitting (right). Covariance of fit (covfit) = 
4.57 x 10-4. Link to Bindfit fitting: http://app.supramolecular.org/bindfit/view/a3a8083e-2d82-4ce7-
8eb8-8c326a21b893. 
Covariance of fit (covfi t) = 4.57  x 10-4.  Link to  Bindfit  fitting: http ://app. supramolecular.org/bindfi t/view/a3a8083e-2d82-4ce7-8eb8-8c326a21b893. 
 
Figure 47. 1H NMR titration spectra as a stack plot for 2,5-dimethoxy-N-(p-tolyl)benzamide (5 mM) + 
TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 
Figure 48. Fitted binding isotherm of 2,5-dimethoxy-N-(p-tolyl)benzamide + TBACl showing the 
change in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka = 1.48 M-1 Residual 
plot showing the random error obtained from the binding isotherm fitting (right). Covariance of fit 
(covfit) = 5.34 x 10-3. Link to Bindfit fitting: http://app.supramolecular.org/bindfit/view/6f20ff00-a6c8-
4bd6-9451-accc783b3fb0. Link to Bindfit fitting: http://app.supramolecular.org/bindfit/view/6f20ff00-
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Figure 49. 1H NMR titration spectra as a stack plot for N-(4-fluorophenyl)-2,5-dimethoxybenzamide (5 
mM) + TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 
Figure 50. Fitted binding isotherm of N-(4-fluorophenyl)-2,5-dimethoxybenzamide + TBACl showing 
the change in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka = 2.92 M-1 
Residual plot showing the random error obtained from the binding isotherm fitting (right). Covariance 
of fit (covfit) = 8.91 x 10-4. Link to Bindfit fitting: http://app.supramolecular.org/bindfit/view/5bfbd64f-
7e92-4de1-8492-aa930d7321dc. 
 
 Figure 51. 1H NMR titration spectra as a stack plot for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dimethoxybenzamide (5 mM) + TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 
Figure 52. Fitted binding isotherm of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dimethoxybenzamide + 
TBACl showing the change in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka 
= 6.69 M-1 Residual plot showing the random error obtained from the binding isotherm fitting (right). 
Covariance of fit (covfit) = 1.16 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/e6081634-e1d0-49a8-a641-7e7c69fd6d15. 
 
 Figure 53. 1H NMR titration spectra as a stack plot for 2,5-dihydroxy-N-phenylbenzamide (5 mM) + 
TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
  
Figure 54. Fitted binding isotherm of 2,5-dihydroxy-N-phenylbenzamide + TBACl showing the change 
in chemical shift of the OH and NH protons fitted to the 1:1 binding model (left). Ka = 124.85 M-1 
Residual plot showing the random error obtained from the binding isotherm fitting (right). Covariance 
of fit (covfit) = 1.61 x 10-2.  Link to Bindfit fitting: http://app.supramolecular.org/bindfit/view/8ebd8323-
a206-43ad-9482-c8a6625e0288. 
 
 Figure 55. Fitted binding isotherm of 2,5-dihydroxy-N-phenylbenzamide + TBACl showing the change 
in chemical shift of the OH and NH protons fitted to the 2:1 binding model (left) K11 = 112.96 M-1,  
K12 = 679.5 M-1. Residual plot showing the random error obtained from the binding isotherm fitting 
(right). Covariance of fit (covfit) = 1.23 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/6b35f570-2a30-4e86-bc62-e13bdf396c6d.  
 
Figure 56. 1H NMR titration spectra as a stack plot for 2,5-dihydroxy-N-(p-tolyl)benzamide (5 mM) + 
TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 Figure 57. Fitted binding isotherm of N-(4-fluorophenyl)-2,5-dihydroxybenzamide + TBACl showing 
the change in chemical shift of the OH and NH protons fitted to the 1:1 binding model (left) Ka = 41.47 
M-1. Residual plot showing the random error obtained from the binding isotherm fitting (right).  
Covariance of fit (covfit) = 1.56 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/d28e7bd7-dbf9-4532-851d-7a81ca565211. 
 
Figure 58. Fitted binding isotherm of 2,5-dihydroxy-N-(p-tolyl)benzamide + TBACl showing the 
change in chemical shift of the NH protons fitted to the 2:1 binding model (left) K11 = 191.36 M-1, K12 
= 665.6 M-1.Residual plot showing the random error obtained from the binding isotherm fitting (right). 
Covariance of fit (covfit) = 1.28 x 10-4. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/7a990a8d-730c-4de2-b904-2821f4114c32. 
 Figure 59. 1H NMR titration spectra as a stack plot for N-(4-fluorophenyl)-2,5-dihydroxybenzamide (5 
mM) + TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 
Figure 60. Fitted binding isotherm of N-(4-fluorophenyl)-2,5-dihydroxybenzamide + TBACl showing 
the change in chemical shift of the OH and NH protons fitted to the 1:1 binding model (left) Ka = 125.55 
M-1. Residual plot showing the random error obtained from the binding isotherm fitting (right). 
Covariance of fit (covfit) = 9.07 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/d1dfa649-4fa8-4dc9-9486-54fa7b6dc005. 
 
 Figure 61. Fitted binding isotherm of N-(4-fluorophenyl)-2,5-dihydroxybenzamide + TBACl showing 
the change in chemical shift of the downfield OH and NH protons fitted to the 2:1 binding model (left) 
K11 = 30.76 M-1, K12 = 517.79 M-1.Residual plot showing the random error obtained from the binding 
isotherm fitting (right). Covariance of fit (covfit) = 8.61 x 10-4. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/1ebd9451-9a97-44e0-b04a-f0da4ec9da66. 
 
Figure 62. 1H NMR titration spectra as a stack plot for N-(3,5-bis(trifluoromethyl)phenyl)-2,5-
dihydroxybenzamide (5 mM) + TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 Figure 63. Fitted binding isotherm of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dihydroxybenzamide + 
TBACl showing the change in chemical shift of the OH and NH protons fitted to the 1:1 binding model 
(left). Ka = 173.50 M-1. Residual plot showing the random error obtained from the binding isotherm 
fitting (right). Covariance of fit (covfit) = 1.41 x 10-2. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/3c5571ea-697b-415b-a44c-eef7bc4a492d. 
 
Figure 64. Fitted binding isotherm of N-(3,5-bis(trifluoromethyl)phenyl)-2,5-dihydroxybenzamide + 
TBACl showing the change in chemical shift of the OH and NH protons fitted to the 2:1 binding model 
(left) K11 = 54.44 M-1, K12 = 336.49 M-1. Residual plot showing the random error obtained from the  
binding isotherm fitting (right). Covariance of fit (covfit) = 1.42 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/b5da4bd0-0c39-48e6-b0d6-7ca3dc5d4c32. 
 Figure 65. 1H NMR titration spectra as a stack plot for 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-
carboxamide (5 mM) + TBACl in CD3CN-d3 /1% DMSO-d6 at 298 K. 
 
Figure 66. Fitted binding isotherm of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide + TBACl 
showing the change in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka = 12.57 
M-1 Residual plot showing the random error obtained from the binding isotherm fitting (right). 
Covariance of fit (covfit) = 1.19 x 10-4. Link to Bindfit: 
http://app.supramolecular.org/bindfit/view/c47caa71-aa70-4477-8ff5-a03f89cf0970. 
 Figure 67. 1H NMR titration spectra as a stack plot for 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-
carboxamide (5 mM) + TBACl in pure CD3CN-d3 at 298 K. 
 
Figure 68. Fitted binding isotherm of 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide + TBACl 
in pure acetonitrile, showing the change in chemical shift of the NH proton fitted to the 1:1 binding 
model (left). Ka = 11.2 M-1 Residual plot showing the random error obtained from the binding isotherm 
fitting (right). Covariance of fit (covfit) = 7.59 x 10-5. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/0e8c07c2-f323-421f-9064-7fd84b33b6ee. 
 Figure 69. 1H NMR titration spectra as a stack plot for 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-
carboxamide (5 mM) + TBACl in CD3CN-d3 at 298 K. 
 
Figure 70. Fitted binding isotherm of 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide + 
TBACl showing the change in chemical shift of the NH proton fitted to the 1:1 binding model (left). Ka 
= 11.39 M-1 Residual plot showing the random error obtained from the binding isotherm fitting (right). 
Covariance of fit (covfit) = 3.79 x 10-4. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/702ba05b-af22-41f8-92d3-03851c9bbfa4. change in 
chemica
 
Figure 71. 1H NMR titration spectra as a stack plot for N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-
diene-1-carboxamide (5mM) + TBACl in CD3CN-d3 at 298 K. 
 
Figure 72. Fitted binding isotherm of N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide + TBACl, showing the change in chemical shift of the NH proton fitted to the 1:1 binding 
model (left). Ka = 19.64 M-1 Residual plot showing the random error obtained from the binding isotherm 
fitting (right). Covariance of fit (covfit) = 1.39 x 10-3. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/c1e8a021-5a3e-449d-9029-c877be8af61f. 
 Figure 73. 1H NMR titration spectra as a stack plot for N-(3,5-bis(trifluoromethyl)phenyl)-3,6-
dioxocyclohexa-1,4-diene-1-carboxamide (5mM) + TBACl in CD3CN-d3 at 298 K. 
 
Figure 74. Fitted binding isotherm of N-(3,5-bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-1,4-
diene-1-carboxamide + TBACl showing the change in chemical shift of NH proton fitted to the 1:1 
binding model (left). Ka = 68.05 M-1 Residual plot showing the random error obtained from the binding 
isotherm fitting (right). Covariance of fit (covfit) = 8.60 x 10-4. Link to Bindfit fitting: 
http://app.supramolecular.org/bindfit/view/e26132bd-3fcb-428f-a064-18bd69f38557. 
4. Electrochemical Studies  
Equipment and Procedure 
A Basi electrochemical workstation was used for cyclic voltammetry (CV). Initial CV 
measurements were performed in 0.1 M TBAPF6/CH3CN solution at a scan rate of 100mVs
-1 
ranging from 800 mV to -1000 mV.  All experiments were carried out at room temperature 
with three electrode system. A 1 mm diameter glassy carbon(GC) electrode was used as 
working electrode, the Ag/AgCl electrode as psuedoreference electrode, and platinum wire as 
the auxiliary electrode. Ferrocene was added to the solution and potentials were referenced 
against the Fc/Fc+ redox couple.  
Scan rate experiments were also undertaken using a Basi electrochemical workstation. 
Measurements were performed in 0.1 M TBAPF6 solution and scan rate was varied from 20 
mVs-1 to 300 mVs-1 between the voltage range of 560 mV to -1000 mV. Voltammograms were 
recorded for every 20 mVs-1 in scan rate. A 1 mm diameter glassy carbon(GC) electrode was 
used as working electrode, the Ag/AgCl electrode as psuedoreference electrode, and platinum 
wire as the auxiliary electrode. Ferrocene was added to the solution for reference, however only 
peak current data was used for further analysis.  
 
 
 
 
 
 
 
 
 
Cyclic Voltammograms 
 
Figure 75. Cyclic Voltammogram of compound 5 3,6-dioxo-N-phenylcyclohexa-1,4-diene-1-
carboxamide at 100 mVs-1 in the presence of Fc/Fc+. 
 
Figure 76. Cyclic Voltammogram of compound 6 3,6-dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-
carboxamide at 100 mVs-1 in the presence of Fc/Fc+. 
 Figure 77. Cyclic Voltammogram of compound 7 N-(4-fluorophenyl)-3,6-dioxocyclohexa-1,4-diene-1-
carboxamide at 100 mVs-1 in the presence of Fc/Fc+. 
 
Figure 78. Cyclic Voltammogram of compound 8 N-(3,5-bis(trifluoromethyl)phenyl)-3,6-
dioxocyclohexa-1,4-diene-1-carboxamide at 100 mVs-1 in the presence of Fc/Fc+. 
 
 
Scan Rate Experiments 
 
Figure 79. Series of cyclic voltammograms of compound 5 3,6-dioxo-N-phenylcyclohexa-1,4-
diene-1-carboxamide taken from scan rate 20 mVs-1 to 300 mVs-1. The current response increases 
with faster scan rates. 
 
Figure 80. Plot of the root of scan rate (v1/2) against peak current (Ip,c) for  compound 5 3,6-
dioxo-N-phenylcyclohexa-1,4-diene-1-carboxamide. The red line shows the line of best fit through the 
origin, the blue line shows the true line of best fit.  
 Figure 81. Series of cyclic voltammograms of compound 6 3,6-dioxo-N-(p-tolyl)cyclohexa-
1,4-diene-1-carboxamide taken from scan rate 20 mVs-1 to 300 mVs-1. The current response 
increases with faster scan rates. 
 
Figure 82. Plot of the root of scan rate (v1/2) against peak current (Ip,c) for  compound 6 3,6-
dioxo-N-(p-tolyl)cyclohexa-1,4-diene-1-carboxamide. The red line shows the line of best fit 
through the origin, the blue line shows the true line of best fit. 
 Figure 83. Series of cyclic voltammograms of compound 7 N-(4-fluorophenyl)-3,6-
dioxocyclohexa-1,4-diene-1-carboxamide taken from scan rate 20 mVs-1 to 300 mVs-1. The 
current response increases with faster scan rates. 
 
Figure 84. Plot of the root of scan rate (v1/2) against peak current (Ip,c) for  7 N-(4-fluorophenyl)-
3,6-dioxocyclohexa-1,4-diene-1-carboxamide. The red line shows the line of best fit through 
the origin, the blue line shows the true line of best fit. 
 Figure 85. Series of cyclic voltammograms of compound 8 N-(3,5-bis(trifluoromethyl)phenyl)-
3,6-dioxocyclohexa-1,4-diene-1-carboxamide taken from scan rate 20 mVs-1 to 300 mVs-1. The 
current response increases with faster scan rates. 
 
Figure 86. Plot of the root of scan rate (v1/2) against peak current (Ip,c) for  8 N-(3,5-
bis(trifluoromethyl)phenyl)-3,6-dioxocyclohexa-1,4-diene-1-carboxamide. The red line shows 
the line of best fit through the origin, the blue line shows the true line of best fit. 
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